πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 61 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 12421236

Seven-membered heterocyclic derivative acting as KRAS G12C mutant protein inhibitor

Medshine Discovery Inc. Β· Granted Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12351587

Bicyclic compound as RIP-1 kinase inhibitor and application thereof

Medshine Discovery Inc. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12351590

Pyrrolopyrimidine compound and use thereof

Medshine Discovery Inc. Β· Granted Tue Jul 08 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 03 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12338218

Crystal form of benzimidazole-2-one compound, solvate thereof, crystal form of solvate the

Medshine Discovery Inc. Β· Granted Tue Jun 24 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12258367

Glucoside derivative that acts as SGLT1 inhibitor and application thereof

Medshine Discovery Inc. Β· Granted Tue Mar 25 2025 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 12030897

Pyrrolo[2,1-f][1,2,4]triazine derivatives serving as selective HER2 inhibitors and applica

Medshine Discovery Inc. Β· Granted Tue Jul 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11905276

Bicyclic compound that acts as CRBN protein regulator

Medshine Discovery Inc. Β· Granted Tue Feb 20 2024 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11814371

Heterocyclic compound

Medshine Discovery Inc. Β· Granted Tue Nov 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11718610

Compounds containing benzosultam

Medshine Discovery Inc. Β· Granted Tue Aug 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 03 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11702400

Salt types, crystal forms, and preparation methods for benzopyrazole compounds as RHO kina

Medshine Discovery Inc. Β· Granted Tue Jul 18 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 13 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11691974

3,9-diazaspiro[5,5]undecane compound as FLT3 and AXL inhibitors

Medshine Discovery Inc. Β· Granted Tue Jul 04 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11680070

Thieno[2,3-c]pyridazin-4(1H)-one derivative and application thereof

Medshine Discovery Inc. Β· Granted Tue Jun 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 15 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11673899

Crystal form of thieno[2,3-c]pyridazine-4(1H)-one compound, preparation method therefor an

Medshine Discovery Inc. Β· Granted Tue Jun 13 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 08 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11655248

Pyridone-pyrimidine derivative acting as KRAS G12C mutein inhibitor

Medshine Discovery Inc. Β· Granted Tue May 23 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 18 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11649239

Crystal form a of (5-amino-8-(2-methyl-6-(trifluoromethyl)pyridin-4-yl)-7-phenyl-[1,2,4]tr

Medshine Discovery Inc. Β· Granted Tue May 16 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 11 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11639355

Substituted pyrrolo[3,4-d]imidazoles as MDM2-p53 inhibitors

Medshine Discovery Inc. Β· Granted Tue May 02 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 27 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11634424

Diazaindole derivative and use thereof as CHK1 inhibitor

Medshine Discovery Inc. Β· Granted Tue Apr 25 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 20 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11623923

Uracil compound as c-MET/AXL inhibitor

Medshine Discovery Inc. Β· Granted Tue Apr 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Apr 06 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11578081

Crystal form as inhibitor of ACC1 and ACC2, and preparation method therefor and use thereo

Medshine Discovery Inc. Β· Granted Tue Feb 14 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 09 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11572372

Anti-HBVtetrahydroisoxazolo[4,3-c]pyridine compounds

Medshine Discovery Inc. Β· Granted Tue Feb 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11466024

Bicylic compound acting as an inhibitor

Medshine Discovery Inc. Β· Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11465995

Crystal and salt forms of tricyclic compound and preparation process thereof

Medshine Discovery Inc. Β· Granted Tue Oct 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 06 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11459323

Monocyclic Ξ²-lactam compound for treating bacterial infection

Medshine Discovery Inc. Β· Granted Tue Oct 04 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 11453667

Pyridone-pyrimidine derivative acting as KRASG12C mutein inhibitor

Medshine Discovery Inc. Β· Granted Tue Sep 27 2022 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 22 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

granted